药物对比
Tirzepatide vs Dulaglutide
比较 Tirzepatide（Mounjaro）与 Dulaglutide（Trulicity）治疗 2 型糖尿病。双重 GIP/GLP-1 vs GLP-1 激动剂：A1C、体重减轻、每周注射、胃肠道影响、甲状腺警告。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes considering a switch from a GLP-1 agonist like Trulicity to a dual GIP/GLP-1 agonist like Mounjaro for greater efficacy.
结论
Tirzepatide typically offers superior A1C and weight-loss benefits versus Dulaglutide while sharing similar weekly injection and safety profiles.
全部药物对比